Canaccord Genuity Cuts PT and Estimates on Dendreon (DNDN); Going Off the Rails on a Crazy Train
Tweet Send to a FriendGet Alerts DNDN Hot Sheet
Price: $3.99 -2.21%
Rating Summary:
5 Buy, 15 Hold, 12 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
5 Buy, 15 Hold, 12 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade DNDN Now!
Canaccord Genuity maintains a 'Hold' on Dendreon (NASDAQ: DNDN) price target of $6.00 (from $11.00).
Analyst, Salveen Richter, said, "DNDN reported Q2 Provenge net revenue of $80.0M, below consensus of $85.8M and CGe of $84.9M and sequentially down QoQ (-2.4% vs. low-single-digit growth guidance; not attributed to Zytiga), simultaneously with a strategic restructuring to reduce costs by ~$150M annually..."
"We revising our FY12-FY16 Provenge revenue estimates downwards to account for current trends, lowering COGS given the plant closure and R&D and SG&A expense in accordance with the restructuring, and accounting for a ~$70M non-cash restructuring charge in Q3/12. This results in a decrease in our GAAP EPS estimates for FY12, ($2.98) from ($2.51), and beyond. Q2 GAAP EPS was ($0.65), below consensus of ($0.59) and roughly in line with CGe of ($0.66)."
For an analyst ratings summary and ratings history on Dendreon click here. For more ratings news on Dendreon click here.
Shares of Dendreon closed at $6.18 yesterday, with a 52 week range of $5.69-$37.72.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Salveen Richter, said, "DNDN reported Q2 Provenge net revenue of $80.0M, below consensus of $85.8M and CGe of $84.9M and sequentially down QoQ (-2.4% vs. low-single-digit growth guidance; not attributed to Zytiga), simultaneously with a strategic restructuring to reduce costs by ~$150M annually..."
"We revising our FY12-FY16 Provenge revenue estimates downwards to account for current trends, lowering COGS given the plant closure and R&D and SG&A expense in accordance with the restructuring, and accounting for a ~$70M non-cash restructuring charge in Q3/12. This results in a decrease in our GAAP EPS estimates for FY12, ($2.98) from ($2.51), and beyond. Q2 GAAP EPS was ($0.65), below consensus of ($0.59) and roughly in line with CGe of ($0.66)."
For an analyst ratings summary and ratings history on Dendreon click here. For more ratings news on Dendreon click here.
Shares of Dendreon closed at $6.18 yesterday, with a 52 week range of $5.69-$37.72.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: BofA/Merrill Lynch Upgrades Adobe (ADBE) to Buy
- Deutsche Bank Sees Upside in AIG (AIG) Stock
- UPDATE: Raymond James Downgrades Gevo, Inc. (GEVO) to Market Perform
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Canaccord Genuity
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
